Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 21;10(8):e0135937.
doi: 10.1371/journal.pone.0135937. eCollection 2015.

Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study

Peter A Newman  1 , Clara Rubincam  1 , Catherine Slack  2 , Zaynab Essack  2 , Venkatesan Chakrapani  3 , Deng-Min Chuang  1 , Suchon Tepjan  1 , Murali Shunmugam  3 , Surachet Roungprakhon  4 , Carmen Logie  1 , Jennifer Koen  2 , Graham Lindegger  2
Affiliations

Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study

Peter A Newman et al. PLoS One. .

Abstract

Objectives: Broad international guidelines and studies in the context of individual clinical trials highlight the centrality of community stakeholder engagement in conducting ethically rigorous HIV prevention trials. We explored and identified challenges and facilitators for community stakeholder engagement in biomedical HIV prevention trials in diverse global settings. Our aim was to assess and deepen the empirical foundation for priorities included in the GPP guidelines and to highlight challenges in implementation that may merit further attention in subsequent GPP iterations.

Methods: From 2008-2012 we conducted an embedded, multiple case study centered in Thailand, India, South Africa and Canada. We conducted in-depth interviews and focus groups with respondents from different trial-related subsystems: civil society organization representatives, community advocates, service providers, clinical trialists/researchers, former trial participants, and key HIV risk populations. Interviews/focus groups were recorded, and coded using thematic content analysis. After intra-case analyses, we conducted cross-case analysis to contrast and synthesize themes and sub-themes across cases. Lastly, we applied the case study findings to explore and assess UNAIDS/AVAC GPP guidelines and the GPP Blueprint for Stakeholder Engagement.

Results: Across settings, we identified three cross-cutting themes as essential to community stakeholder engagement: trial literacy, including lexicon challenges and misconceptions that imperil sound communication; mistrust due to historical exploitation; and participatory processes: engaging early; considering the breadth of "community"; and, developing appropriate stakeholder roles. Site-specific challenges arose in resource-limited settings and settings where trials were halted.

Conclusions: This multiple case study revealed common themes underlying community stakeholder engagement across four country settings that largely mirror GPP goals and the GPP Blueprint, as well as highlighting challenges in the implementation of important guidelines. GPP guidance documents could be strengthened through greater focus on: identifying and addressing the community-specific roots of mistrust and its impact on trial literacy activities; achieving and evaluating representativeness in community stakeholder groups; and addressing the impact of power and funding streams on meaningful engagement and independent decision-making.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Conceptual model of multiple case study design.
CSO: civil society organization, *Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials [1]. **GPP Blueprint for Stakeholder Engagement (AVAC) [7].
See this image and copyright information in PMC

References

    1. UNAIDS-AVAC. Good participatory practice: guidelines for biomedical HIV prevention trials UNAIDS; Published June, 2011 [cited 2015 Feb 11]. Available from: http://www.unaids.org/sites/default/files/media_asset/JC1853_GPP_Guideli....
    1. Singh J, Mills E. The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong? PLoS Med. 2005;2(9):e234 - PMC - PubMed
    1. Ukpong M, Peterson K. Oral tenofovir controversy II: voices from the field, a series of reports of the oral tenofovir trials from the perspectives of active stakeholder voices engaged on the field in Cambodia, Cameroon, Nigeria, Thailand and Malawi New HIV Vaccine and Microbicide Advocacy Society (NHVMAS). Published 2009 [cited 2015 Feb 11]. Available from: http://www.nhvmas-ng.org/publication/TDF2.pdf.
    1. McGrory E, Irvin A, Heise L. Research Rashomon: lessons from the Cameroon pre-exposure prophylaxis trial site Global campaign for microbicides; Published 2009 [cited 2015 Feb 11]. Available from: www.global-campaign.org/clientfiles/Cameroon.pdf.
    1. UNAIDS-AVAC. Good participatory practice: guidelines for biomedical HIV prevention trials UNAIDS; Published November, 2007 [cited 2015 Feb 11]. Available from: http://whqlibdoc.who.int/unaids/2007/9789291736348_eng.pdf.

Publication types